Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
immunodeficiency 31B
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
10/06/2024
Evidence/Notes:

STAT1 was first reported to be implicated in Immunodeficiency 31B, viral and mycobacterial infections, autosomal recessive, in 2003 (Dupuis et al., PMID: 12590259).

6 Variants (missence and frameshift) that have been reported in 7 probands in 5 publications are included in this curation (PMIDs: 12590259, 16585605, 20841510, 21772053, 32603902). The mechanism of pathogenicity is reported to be loss of function. Absence or impaired protein expression and the abolition or impaired cellular responses to IFN-γ, IFN-α/β, or IFN-λ, are demonstrated in the patients affected, leading to severe and potentially fatal mycobacterial and viral infections.

This gene- disease relationship is also supported by experimental evidence. Enriched STAT1 expression was detected in EBV-transformed B cells (PMID 23715323). Nuclear extracts of HeLaS3 cells treated with IFN-γ and IFN-α showed an increase in nuclear localization of STAT1 (PMID: 16319195). Activation of ISGF3 by IFN-α is shown to be impaired in cells of the patients homozygous with respect to the mutated STAT1 alleles. No IFN-stimulated response element (ISRE)–binding activity was detected in nuclear extracts from the mutated in response to IFN-α (PMID: 12590259). Electrophoretic mobility shift assay (EMSA) showed no γ-activated sequence (GAS)–binding proteins in response to IFN-γ in STAT1 mutant cell. A similar defect was shown in a patient with complete IFN-γR1 deficiency (PMID: 12590259).

In summary, there is definitive evidence supporting the relationship between STAT1 and immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld overtime.

PubMed IDs:
12590259 16585605 20841510 21772053 23715323 32603902
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.